US agree for Female Viagra
A panel of federal advisers will soon wrestle with a question that has bedeviled poets, philosophers and generations of frustrated men: What do women want?
That enigma will be part of a Food and Drug Administration committee’s deliberations on June 18 when it considers endorsing the first pill designed to do for women what Viagra did for men: boost their sex lives.
A German pharmaceutical giant wants to sell a drug with the unsexy name “flibanserin”.
The prospect of the drug’s approval has triggered debate over whether the medication represents a long-sought step toward equity for women’s health or the latest example of the pharmaceutical industry fabricating a questionable disorder to sell unnecessary drugs.
“Achieving a happy and healthy sex life can be a real and important problem for some women,” said Amy Allina of the National Women’s Health Network.
“But we have lots of questions about the pink Viagra.”
















